Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy

Sahaja Acharya, Jacqueline Esthappan, Shahed Badiyan, Todd DeWees, Kari Tanderup, Julie K. Schwarz, Perry W. Grigsby

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background and purpose High BMI is a reason for medical inoperability in patients with endometrial cancer in the United States. Definitive radiation is an alternative therapy for these patients; however, data on patterns of failure after definitive radiotherapy are lacking. We describe the patterns of failure after definitive treatment with 3-D image-based high dose rate (HDR) brachytherapy for medically inoperable endometrial cancer. Materials and methods Forty-three consecutive patients with endometrial cancer FIGO stages I-III were treated definitively with HDR brachytherapy with or without external beam radiation therapy. Cumulative incidence of failures was estimated and prognostic variables were identified Results Mean follow up was 29.7 months. Median BMI was 50.2 kg/m2 (range: 25.1-104 kg/m2). The two-year overall survival was 65.2%. The two-year cumulative incidence of pelvic and distant failures was 8.3% and 13.5%, respectively. Grade 3 disease was associated with a higher risk of all-failures (Hazard Ratio [HR]: 4.67, 95% CI: 1.04-20.9, p = 0.044). The incidence of acute Grade 3 GI/GU toxicities was 4.6%. Conclusions Pelvic failure at two years was less than 10%. Patients with grade 3 disease were more likely to experience disease failure and may warrant closer follow up.

Original languageEnglish (US)
Pages (from-to)167-172
Number of pages6
JournalRadiotherapy and Oncology
Volume118
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Keywords

  • Brachytherapy
  • Endometrial cancer
  • Inoperable
  • Obesity

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Medically inoperable endometrial cancer in patients with a high body mass index (BMI): Patterns of failure after 3-D image-based high dose rate (HDR) brachytherapy'. Together they form a unique fingerprint.

  • Cite this